Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial

Guillaume Janoray , Yoann Pointreau , Marc Alfonsi (1) , Christian Sire , Lionel Geoffrois (2) , Dominique de Raucourt (3) , Etienne Bardet (4) , Marie-Hélène Calais , Pascal Garaud , Gilles Calais

1 Institut Sainte Catherine [Avignon]
2 UNICANCER/ICL - Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy]
3 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
4 Centre René Gauducheau

Domains: Life Sciences [q-bio]

Guillaume Janoray, Yoann Pointreau, Marc Alfonsi, Christian Sire, Lionel Geoffrois, et al.. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer, 2020, 133, pp.86 - 93. ⟨10.1016/j.ejca.2020.04.009⟩. ⟨hal-03490774⟩